News and Press Releases
Press releases
Theralase Release’s Q222 Interim Financial Statements
Toronto, Ontario – August 29, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical ...
0Theralase Expands Intellectual Property Portfolio
Toronto, Ontario – June 28, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical ...
0Theralase® Research – One of the Top 10 Most Downloaded Papers
Toronto, Ontario – June 24, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical sta...
0Theralase® Phase Ib NMIBC Clinical Study Published
Toronto, Ontario – June 21, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical st...
0Theralase Releases Q122 Interim Financial Statements
Toronto, Ontario – May 30, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical sta...
0Theralase Release FY2021 Audited Financial Statements
Toronto, Ontario – April 29, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical st...
0Theralase® Provides Update on Phase II Bladder Cancer Clinical Study
Toronto, Ontario – April 5, 2022, Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical sta...
0Theralase® Demonstrates Proof-of-Concept for Canadian-Made COVID-19 Vaccine
Toronto, Ontario – February 7, 2022, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase® Expands Intellectual Property Portfolio
Toronto, Ontario – December 9, 2021, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinica...
0Theralase Releases 3Q21 Financial Statements and Newsletter
Toronto, Ontario – November 29, 2021, Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinic...
0in the news
July 6, 2023
Vrian Crombie Radio Interview with Roger DuMoulin-White - President and Chief Executive Officer
may 18, 2023
Promising Developments in the Theralase® Project of Intravesical Photodynamic Therapy for BCG Unresponsive Bladder Cancer - Girish Kulkarni
Let's Stay in Touch
Sign up to our newsletter to stay informed on news and updates from Theralase Technologies Inc.